BCL2A1 and Miyoshi myopathy: Furthermore, blocking CD84 using the B4 antibody on whole cultures of primary patient MM BM, also reduced the expression of CMTM6 (Figure 9D), BCL2A1 (Figure 9E), and HIF1α (Figure 9F).